SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001613377-18-000017
Filing Date
2018-07-23
Accepted
2018-07-23 09:32:10
Documents
1
Period of Report
2018-07-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2976
  Complete submission text file 0001613377-18-000017.txt   4444
Mailing Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801
Business Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801 407-271-8516
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 600 MAIN STREET SUITE 2 RIVERTON NJ 08077
Business Address
PASCALE ADAM (Reporting) CIK: 0001613377 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-27072 | Film No.: 18963730